COVID-19 impact on an oncologic emergency department visits : observational study
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ..
OBJECTIVE: This study aimed at evaluating the impact of COVID-19 on emergency department (ED) visits in a tertiary cancer centre and providing information on the features of the unplanned events during the first wave of COVID-19 pandemic.
METHODS: This retrospective observational study based on data from ED reports was divided into three periods of 2 months each around the first lockdown announcement of 17 March 2020: pre-lockdown, lockdown and post-lockdown.
RESULTS: A total of 903 ED visits were included in the analyses. The mean (±SD) daily number of ED visits did not change during the lockdown period (14.6±5.5) when compared with the periods before (13.6±4.5) and after lockdown (13.7±4.4) (p=0.78). The proportion of ED visits for fever and respiratory disorders increased significantly to 29.5% and 28.5%, respectively (p<0.01) during lockdown. Pain, the third most frequent motive, remained stable with 18.2% (p=0.83) throughout the three periods. Symptom severity also showed no significant differences in the three periods (p=0.31).
CONCLUSION: Our study shows that ED visits during the first wave of the COVID-19 pandemic remained stable for our patients regardless of the symptom's severity. The fear of an in-hospital viral contamination appears weaker than the need for pain management or for the treatment of cancer-related complications. This study highlights the positive impact of cancer ED in the first-line treatment and supportive care of patients with cancer.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - year:2023 |
---|---|
Enthalten in: |
BMJ supportive & palliative care - (2023) vom: 22. Feb. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Ram, Aurélie [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Revised 16.02.2024 published: Print-Electronic Citation Status Publisher |
---|
doi: |
10.1136/spcare-2023-004184 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM35319803X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM35319803X | ||
003 | DE-627 | ||
005 | 20240216232519.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1136/spcare-2023-004184 |2 doi | |
028 | 5 | 2 | |a pubmed24n1295.xml |
035 | |a (DE-627)NLM35319803X | ||
035 | |a (NLM)36813536 | ||
035 | |a (PII)spcare-2023-004184 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Ram, Aurélie |e verfasserin |4 aut | |
245 | 1 | 0 | |a COVID-19 impact on an oncologic emergency department visits |b observational study |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 16.02.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status Publisher | ||
520 | |a © Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. | ||
520 | |a OBJECTIVE: This study aimed at evaluating the impact of COVID-19 on emergency department (ED) visits in a tertiary cancer centre and providing information on the features of the unplanned events during the first wave of COVID-19 pandemic | ||
520 | |a METHODS: This retrospective observational study based on data from ED reports was divided into three periods of 2 months each around the first lockdown announcement of 17 March 2020: pre-lockdown, lockdown and post-lockdown | ||
520 | |a RESULTS: A total of 903 ED visits were included in the analyses. The mean (±SD) daily number of ED visits did not change during the lockdown period (14.6±5.5) when compared with the periods before (13.6±4.5) and after lockdown (13.7±4.4) (p=0.78). The proportion of ED visits for fever and respiratory disorders increased significantly to 29.5% and 28.5%, respectively (p<0.01) during lockdown. Pain, the third most frequent motive, remained stable with 18.2% (p=0.83) throughout the three periods. Symptom severity also showed no significant differences in the three periods (p=0.31) | ||
520 | |a CONCLUSION: Our study shows that ED visits during the first wave of the COVID-19 pandemic remained stable for our patients regardless of the symptom's severity. The fear of an in-hospital viral contamination appears weaker than the need for pain management or for the treatment of cancer-related complications. This study highlights the positive impact of cancer ED in the first-line treatment and supportive care of patients with cancer | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a Cancer | |
650 | 4 | |a Supportive care | |
700 | 1 | |a Pagès, Arnaud |e verfasserin |4 aut | |
700 | 1 | |a Cubilier, Edouard |e verfasserin |4 aut | |
700 | 1 | |a Daoudi, Nesrine |e verfasserin |4 aut | |
700 | 1 | |a Vandergheynst, Frederic |e verfasserin |4 aut | |
700 | 1 | |a Scotte, Florian |e verfasserin |4 aut | |
700 | 1 | |a Antoun, Sami |e verfasserin |4 aut | |
700 | 1 | |a Merad, Mansouriah |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t BMJ supportive & palliative care |d 2011 |g (2023) vom: 22. Feb. |w (DE-627)NLM226675734 |x 2045-4368 |7 nnns |
773 | 1 | 8 | |g year:2023 |g day:22 |g month:02 |
856 | 4 | 0 | |u http://dx.doi.org/10.1136/spcare-2023-004184 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |j 2023 |b 22 |c 02 |